SPAC

Investcorp AI's deal with Blue Finance aims to bring AI-powered lending to the global underbanked, navigating a tricky market for SPACs and fintech.

A SPAC deal aims to list one of America's largest lithium resources on NASDAQ, fueling the high-stakes race for domestic battery minerals.

Miotal plans a Nasdaq debut via a SPAC merger, offering investors a unique play on critical materials, but questions about its vast inventory remain.

A new partnership aims to use quantum computing to solve the biggest hurdle for plant-based food: making it taste and feel like the real thing.

Apogee Acquisition Corp. prices its IPO, joining a resurgent SPAC market with a sharp focus on acquiring a transformative advanced technology company.

The merger meant to launch a new-economy bank now includes a massive iron mine, raising questions about strategy, valuation, and management expertise.

Automotive tech firm Carvix is merging with a SPAC in a billion-dollar deal, aiming to use data and capital to roll up the fragmented auto repair industry.

Dubai's AIR, owner of Al Fakher, is going public via a SPAC merger. Can it navigate a tricky market and health debates to find growth on Wall Street?

BHAV Acquisition Corp's $100M IPO signals a hunt for a tech unicorn in robotics or AI, led by a seasoned Nasdaq veteran in a resurgent SPAC market.

A SPAC deal aims to bring Hong Kong's AI-driven waste sorter Rongcheng public, highlighting a major bet on the future of green technology and recycling.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

AI infrastructure firm GoodVision AI merges with Calisa Acquisition Corp to go public, aiming to solve the critical AI inference challenge with new capital.

As it prepares for a Nasdaq listing, quantum software firm Horizon Quantum brings in veterans from Apple, Grab, and Broadcom to navigate its public future.

After its public debut, BBOT unveils exciting early data from three unique cancer drugs, including a first in pancreatic cancer, backed by a strong cash runway.

Backed by Nobel-winning science and French state support, Pasqal's move to go public validates the commercial promise of deep quantum technology.

Singapore fintech EFGH taps media pioneer Woon Tai Ho for its board, bolstering governance as it pursues a $425M U.S. listing via a SPAC merger.

Shareholder approval paves the way for cancer therapy innovator VERAXA to go public, aiming to accelerate its next-gen antibody-drug conjugate pipeline.

TRG Latin America Acquisitions Corp. raises $200M in an IPO, targeting Argentina with the backing of emerging market veterans from The Rohatyn Group.

Trump Media plans a complex deal to spin off Truth Social after its fusion energy merger, aiming to create two distinct publicly traded companies.

Sustainable energy provider ThomasLloyd is merging with a SPAC to go public, aiming to solve the massive power crisis facing the booming AI industry.